Effects of a High Viscosity Dietary Fibre, as Part of a Medically Supervised Weight Management Program

Canadian Center for Functional Medicine

Overview

The aim of this study is to investigate whether the supplementation of a medically supervised weight management program with a novel fibre supplement, improves body weight, body composition, and laboratory measurements in overweight and obese individuals. All subjects will participate in the medical weight management program however the intervention group will have 5 grams of a novel fibre supplemented to each meal while the control group will not.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Conditions

Obesity

Interventions

Novel fibre supplementDIETARY_SUPPLEMENT

The full dose of the study intervention is 15 grams per day.

Eligibility

Sex: ALLMin age: 20 YearsMax age: 55 Years

Medical Language ↔ Plain English

Inclusion Criteria: * BMI 27 - 30 Kg/m2 with 1 weight-related comorbidity and/or BMI 30 - 50 Kg/m2 * Ability to provide written informed consent in accordance with Good Clinical Practice (GCP) and local legislation in English Exclusion Criteria: * Medications and supplements that affect body weight and appetite * Type 2 diabetes on insulin treatment * Contraindications to low calorie diet * Any allergies to study product ingredients * Any other medical, social or geographic condition, which, in the opinion of the investigator would not allow safe completion of the protocol.

Locations (1)

Canadian Centre for Functional Medicine

Coquitlam, British Columbia, Canada

Outcomes

Primary Outcomes

Body weight

Time frame: 52 weeks

Secondary Outcomes

Body composition

Time frame: 52 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.